Hypertension quiz results
Referrals and patient selection
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Referrals and patient selection
An estimated 1.28 billion adults ages 30–79 years worldwide have hypertension, according to the WHO. Most (two-thirds) live in low- and middle-income countries.1
Approximately 1 in 5 adults, or 21%, with hypertension have it under control, according to the WHO.1
According to a meta-analysis of more than 600,000 participants in 123 studies, a 10 mmHg reduction in blood pressure reduces the risk of heart failure by 28%.2
Explore resources for identifying patients who could benefit from the Symplicity™ blood pressure procedure.
See how the Symplicity blood pressure procedure has demonstrated significant and safe blood pressure reductions.1–3
Use these patient-friendly resources to educate patients about the Symplicity blood pressure procedure.
Find resources designed to help you support your patients with hypertension.
Hypertension Key Facts. World Health Organization. Published August 25, 2021. Accessed December 10, 2021.
Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387:957-67.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet. 2020;395:1444-1451.